Prosecution Insights
Last updated: November 04, 2026

Lactiga Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Lactiga Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals sector. The case is assigned to 1 distinct examiner, PRICILA NMN HAUK TEODORO, and 1 distinct art unit. PRICILA NMN HAUK TEODORO is the busiest examiner, responsible for 1 busiest examiner pending action. This 1 pending office action represents the entirety of the company's current activity.

Because there is only 1 pending office action, the entire current strategy for the Biotechnology & Pharmaceuticals area rests with PRICILA NMN HAUK TEODORO. This 1 distinct examiner and 1 distinct art unit combination means that the applicant does not have to navigate multiple examination styles or conflicting art unit policies. Practitioners should focus on the specific prosecution history of PRICILA NMN HAUK TEODORO, as this busiest examiner handles the only busiest examiner pending action in the portfolio. The 1:1 ratio between the pending office action and the distinct examiner ensures that all current efforts are directed toward a single point of contact within the patent office.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAUK TEODORO, PRICILA NMN 1 50.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18562606 Polyclonal Antibodies to Treat Respiratory Syncytial Virus HAUK TEODORO, PRICILA NMN —

Top Art Units

Art UnitApps
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18562606 Polyclonal Antibodies to Treat Respiratory Syncytial Virus HAUK TEODORO, PRICILA NMN 1645 §101§102§103 Non-Final OA — Pending Nov 20, 2023

Managing Lactiga Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Lactiga Inc. have?

Lactiga Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Lactiga Inc. applications?

Pricila Nmn Hauk Teodoro has the most, with 1 of Lactiga Inc.'s pending office actions.

What technology area are Lactiga Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month